論文

国際誌
2021年8月30日

Contradiction between genetic analysis and diuretic loading test in type I Bartter syndrome: a case report.

BMC nephrology
  • Jumpei Kuroda
  • ,
  • Ryoko Harada
  • ,
  • Riku Hamada
  • ,
  • Yusuke Okuda
  • ,
  • Yasuhiro Yoshida
  • ,
  • Hiroshi Hataya
  • ,
  • Kandai Nozu
  • ,
  • Kazumoto Iijima
  • ,
  • Masataka Honda
  • ,
  • Kenji Ishikura

22
1
開始ページ
295
終了ページ
295
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1186/s12882-021-02497-6

BACKGROUND: In typical cases of Bartter syndrome (BS), assessing response to diuretics (furosemide and thiazide), hereinafter referred to as diuretic loading test, may be used to diagnose the type by detecting which part of the kidney tubule is not functioning correctly. However, the diuretic loading test may not always agree with the results of genetic analyses. CASE PRESENTATION: A 5-year-old boy was admitted due to lower extremity weakness and abnormal gait. He had a recurrent episode of muscle weakness and laboratory results showed severe hypokalemia. The direct genomic sequencing of the case revealed a new mutation in the SLC12A1 gene, which is associated with type I Bartter syndrome. Because there was the difference between the phenotype and genotype, we conducted a diuretic loading test to confirm the diagnosis. However, the results showed a clear increase in urine excretion of Na and Cl. These results were not consistent with typical type I BS, but consistent with the patient's phenotype. CONCLUSION: The diuretic loading test has limited utility for diagnosis especially in atypical cases. On the other hand, this test, which allows assessment of channel function, is useful for better understanding of the genotype-phenotype correlation.

リンク情報
DOI
https://doi.org/10.1186/s12882-021-02497-6
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/34461850
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404274
ID情報
  • DOI : 10.1186/s12882-021-02497-6
  • PubMed ID : 34461850
  • PubMed Central 記事ID : PMC8404274

エクスポート
BibTeX RIS